CEO16 May 2019 16:05
Dr. Markku Jalkanen serves as Chief Executive Officer, Founder and Member of the Executive Board at Faron Pharmaceuticals Oy. He has over 25 years of experience in biomedical research, biotech development and the biopharmaceutical industry. He is Former CEO of Biotie Therapies Corp., NASDAQ-listed life science company. He has been Adviser to Finnish Life Sciences Fund, Inveni Capital. He holds Doctorate in Philosophy in Medical Biochemistry and Docent in Biochemistry and Molecular and Cell Biology.